ArticleLipids in health and disease2026
Real-world effectiveness and cardiovascular outcomes of PCSK9 inhibitor therapy: a prospective registry study.
Jan Kafol et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it